- About us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Professionnels de la santé
- Care
- Research
- Our research teams
- Molecular pathology
- Functional precision medicine for leukemia
- Normal and pathological hematopoiesis
- Niche, Cancer, and Radiation in Hematopoiesis
- Population Evolution and Interaction Particle Systems
- Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Identification and targeting of extrinsic regulators of myeloid malignancies
- Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Molecular Mechanisms of Acute Myeloid Leukemia Development
- Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Leukemia & Niche Dynamics
- Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Stem cell dysfunction and secondary AML
- Biostatistics and clinical epidemiology
- Our technological platforms
Accueil Stem cell dysfunction and secondary AMLStem cell dysfunction and secondary AML
...Jean Soulier
Team leader
Research themes
Clonal evolution in bone marrow failure syndrome as Fanconi anemia can result into ‘adaptive’ somatic genetic rescue, rescuing the HSC defect, or into ‘maladaptive’ evolution towards acute myeloid leukemia.
We profile patient samples at the single cell level and model bone marrow evolution using in vitro and mice experimental systems.
The adaptive or maladaptive deregulated pathways involve DNA damage response, inflammation, stem cell homeostasis and myeloid oncogenes.
Data inform on the BM dysfunction and pathway to sAML, with insights for patients staging and follow up.
- Bone marrow failure
- Fanconi anemia
- Aplastic anemia
- Leukemia
- Secondary AML
- MDS
- Genomic instability
Research areas
AML and MDS predisposition
Somatic genetic rescue in bone marrow failure
Featured research projects
Pathogenesis of secondary leukemias
Marie de Tersant
Adaptive somatic genetic rescue in Fanconi anemia
Lise Larcher
Team members
Jean SOULIERPU-PH, UPC and APHPLise LARCHERPharD, doctorante Inserm FRMMarie DE TERSANTMD, doctorante PA InsermChristophe ANTONIEWSKIDR2, CNRS – GenomicsClaude GAZINCRCN, CNRSLoïc MAILLARDPhD, IR, CNRSLucie HERNANDEZAI, UPCVesnie ETIENNEIE, UPC – AnimalsNadia VASQUEZPhD, IG APHP, CRMR AplasieMélanie DA COSTAIG APHP, CRMR AplasieScientific publications
A clickable melphalan for monitoring DNA interstrand crosslink accumulation and detecting ICL repair defects in Fanconi anemia patient cells
Berrada et al, Nucleic Acids Res., 2023Lire la publicationClonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia
Sébert et al, Cell Stem Cell, 2023Lire la publicationFunding
Suivez nos actions en vous inscrivant à la lettre d'information de l’institut
- Become an expert patient
- To be cared for and supported
- Patients and relatives